Small-Molecule Inhibition of PRMT5 Induces Translational Stress and p53 in JAK2V617F Mutant Myeloproliferative Neoplasms

被引：1

作者：

Sonderegger, Stefan ^{[1
]}

Cerruti, Loretta ^{[1
]}

Tremblay, Cedric ^{[1
]}

Toulmin, Emma ^{[1
]}

Saw, Jesslyn ^{[1
]}

Nebl, Tom ^{[2
]}

Hannan, Katherine M. ^{[3
]}

Lane, Steven W. ^{[4
]}

Falk, Hendrik ^{[5
]}

Unnikrishnan, Ashwin ^{[6
]}

Stupple, Paul ^{[7
]}

Street, Ian ^{[5
]}

Jane, Stephen ^{[8
]}

Altura, Rachel ^{[9
]}

Nicholson, Benjamin ^{[10
]}

Curtis, David J. ^{[1
,11
]}

机构：

[1] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia

[2] CSIRO, Biophys Grp, Parkville, Vic, Australia

[3] Australian Natl Univ, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia

[4] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia

[5] Cancer Therapeut CRC, Parkville, Vic, Australia

[6] UNSW Sydney, Sydney, NSW, Australia

[7] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia

[8] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia

[9] Merck Res Labs, Rahway, NJ USA

[10] Merck Res Labs, Boston, MA USA

[11] Alfred Hosp, Dept Clin Haematol, Melbourne, Vic, Australia

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-118406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
Demirkan, F.
Kalkan, S.
Kahraman, S.
Tunali, S.
Katgi, A.
Piskin, O.
Ozcan, M. A.
Ozsan, H. G.
Undar, B.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
[2] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
Sun, Tiantian
Zhang, Lei
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
[3] JAK2V617F-Mutant Vascular Niche Promotes JAK2V617F Clonal Expansion in Myeloproliferative Neoplasms
Zhan, Huichun
Lin, Chi Hua Sarah
Segal, Yarden
Kaushansky, Kenneth
BLOOD, 2016, 128 (22)
[4] JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms
Lin, Chi Hua Sarah
Kaushansky, Kenneth
Zhan, Huichun
BLOOD CELLS MOLECULES AND DISEASES, 2016, 62 : 42 - 48
[5] Enhanced Molecular Response in Myeloproliferative Neoplasms with Complete JAK2V617F Inhibition
Celik, Hamza
Challen, Grant A.
CANCER DISCOVERY, 2024, 14 (05) : 701 - 703
[6] Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)
Dunbar, Andrew
Bowman, Robert L.
Park, Young
Izzo, Franco
Myers, Robert M.
Karzai, Abdul
Kim, Won Jun
Maestre, Ines Fernandez
Waarts, Michael R.
Nazir, Abbas
Xiao, Wenbin
Brodsky, Max
Farina, Mirko
Cai, Louise
Cai, Sheng F.
Wang, Benjamin
An, Wenbin
Yang, Julie
Mowla, Shoron
Eisman, Shira E.
Mishra, Tanmay
Houston, Remie
Guzzardi, Emily
Benitez, Anthony R. Martinez
Viny, Aaron D.
Koche, Richard
Landau, Dan A.
Levine, Ross L.
BLOOD, 2022, 140
[7] JAK2V617F influences epigenomic changes in myeloproliferative neoplasms
Chen, Chih-Cheng
Chiu, Chia-Chen
Lee, Kuan-Der
Hsu, Chia-Chen
Chen, Hong-Chi
Huang, Tim H. -M.
Hsiao, Shu-Huei
Leu, Yu-Wei
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 494 (3-4) : 470 - 476
[8] JAK2V617F allele burden in patients with myeloproliferative neoplasms
Salem H. Alshemmari
Reshmi Rajaan
Reem Ameen
Mohammad A. Al-Drees
Marwa R. Almosailleakh
Annals of Hematology, 2014, 93 : 791 - 796
[9] The Study of Thrombosis in JAK2V617F Mutated Myeloproliferative Neoplasms
Bai, Jie
Zhang, Yuhui
Wang, Yingshao
Teng, Guangshuai
Wang, Yan
Du, Chenxiao
Chen, Yafang
Zhang, Huiqin
Li, Yanqi
Fu, Lixia
Zhang, Lei
Zhou, Yuan
BLOOD, 2019, 134
[10] JAK2V617F allele burden in patients with myeloproliferative neoplasms
Alshemmari, Salem H.
Rajaan, Reshmi
Ameen, Reem
Al-Drees, Mohammad A.
Almosailleakh, Marwa R.
ANNALS OF HEMATOLOGY, 2014, 93 (05) : 791 - 796

← 1 2 3 4 5 →